MoneyWorks4Me

Marksans Pharma informs about disclosure

25 Apr 2022 Evaluate
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that it enclosed Acquisition of Access Healthcare for Medical Products LLC.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..